Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with metabolic syndrome in Iranians with type 2 diabetes mellitus

Archives of Iranian Medicine

Volumn 11, Issue 1, 2008, Pages 3-9

  Nikzamir, Abdolrahim ^a   Nakhjavani, Manouchehr ^a   Golmohamadi, Taghi ^b   Dibai, Ladan ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Angiotensin converting enzyme; Gene polymorphism; Metabolic syndrome; Type 2 diabetes mellitus

Indexed keywords

BIGUANIDE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE; INSULIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC DIET; DISEASE CLASSIFICATION; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; IRAN; KINESIOTHERAPY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MUTATIONAL ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RISK FACTOR; STATISTICAL SIGNIFICANCE; WORLD HEALTH ORGANIZATION;

AGED; AGED, 80 AND OVER; ALLELES; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS, TYPE 2; DNA PRIMERS; FEMALE; GENOTYPE; HUMANS; INSULIN RESISTANCE; IRAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; WORLD HEALTH ORGANIZATION;

EID: 39049118376     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Reaven GM. Banting Lecture. Role of insulin resistance in human disease. Diabetes. 1988; 37: 1595-1607.
2. Zimmet PZ. Kelly West Lecture 1991. Challenges in diabetes epidemiology - from West to the rest. Diabetes Care. 1992; 15: 232-252.
3. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, et al. Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest. 1985; 75: 809-817.
4. De Fronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerotic cardiovascular disease. Diabetes Care. 1991; 14: 173-194.
5. Alberti KG, Zimmet PZ. Definition, diagnosis, and classification of diabetes mellitus and its complications. 1. Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabetes Med. 1998; 15: 539-553.
6. Hansen BC. The metabolic syndrome X. Ann N Y Acad Sci. 1999; 18: 1-24.
7. Isomaa B, Lahti K, Almgren P, Nissen M, Tuomi T, Taskinen MR, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001; 24: 683-689.
8. Groop L. Genetics of the metabolic syndrome. Br J Nutri. 2000; 83 (suppl 1): S39-S84.
9. Mykkanen L, Kuusisto J, Pyorala K, Laakso M. Cardiovascular disease risk factors as predictors of type 2 (noninsulin-dependent) diabetes mellitus in elderly subjects. Diabetologia. 1993; 36: 553-559.
10. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin resistance syndrome (Syndrome X). Diabetes. 1992; 41: 715-722.
11. Nicholls MG, Richards AM, Agarwal M. The importance of the renin-angiotensin system in cardiovascular disease. J Hum Hypertens. 1998; 12: 295-299.
12. Matsusaka T, Hymes J, Ichikawa I. Angiotensin in progressive renal disease: theory and practice. J Am Soc Nephrol. 1996; 7: 2025-2043.
13. Hsieh MC, Lin SR, Hsieh TJ, Hsu CH, Chen HC, Shin SJ, et al. Increased frequency of angiotensin-converting enzyme DD genotype in patients with type 2 diabetes in Taiwan. Nephrol Dial Transplant. 2000; 15: 1008-1013.
14. Pujia A, Gnasso A, Irace C, Dominijanni A, Zingone A, Perrotti N, et al. Association between ACE-D/D polymorphism and hypertension in type II diabetic subjects. J Hum Hypertens. 1994; 8: 687-691.
15. Tiret L, Kee F, Poirier O, Nicaud V, Lecerf L, Evans A, et al. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet. 1993; 341: 991-992.
16. Ruiz J, Blanche H, Cohen N, Velho G, Cambien F, Cohen D, et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary artery disease in noninsulin-dependent diabetes mellitus. Proc Natl Acad Sci USA. 1994; 91: 3662-3665.
17. Navis G, van der Kleij FG, de Zeeuw D, de Jong PE. Angiotensin-converting enzyme gene I/D polymorphism and renal disease. J Mol Med. 1999; 77: 781-791.
18. Nagi DK, Foy CA, Mohamed-Ali V, Yudkin JS, Grant PJ, Knowler WC. Angiotensin-1-converting enzyme (ACE) gene polymorphism, plasma ACE levels, and their association with the metabolic syndrome and electrocardiographic coronary artery disease in Pima Indian. Metabolism. 1998; 47: 622-626.
19. Engeli S, Negrel R, Sharma AM. Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension. 2000; 35: 1270-1277.
20. Marre M, Jeunemaitre X, Gallois Y, Rodier M, Chatellier G, Sert C, et al. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. J Clin Invest. 1997; 99: 1585-1595.
21. Stephens JW, Dhamrait SS, Cooper JA, Acharya J, Miller GJ, Hurel SJ, et al. The D allele of the ACE I/D common gene variant is associated with type 2 diabetes mellitus in Caucasian subjects. Mol Genet Metab. 2005; 84: 83-89.
22. Ding PY, Hu OY, Pool PE, Liao W. Does Chinese ethnicity affect the pharmacokinetics and pharmacodynamics of angiotensin-converting enzyme inhibitors? J Hum Hypertens. 2000. 14: 163-170.
23. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 1992; 51: 197-205.
24. Feng Y, Niu T, Xu X, Chen C, Li Q, Qian R, et al. Insertion/deletion polymorphism of the ACE gene is associated with type 2 diabetes. Diabetes. 2002; 51: 1986-1988.
25. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion deletion polymorphism in angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990; 86: 1343-1346.
26. Chiang FT, Lai ZP, Chern TH, Tseng CD, Hsu KL, Lo HM, et al. Lack of association of the angiotensin-converting enzyme polymorphism with essential hypertension in a Chinese population. Am J Hypertens. 1997; 10: 197-201.
27. Engeli S, Gorzelniak K, Kreutz R, Runkel N, Distler A, Sharma AM. Coexpression of rennin-angiotensin system genes in human adipose tissue. J Hypertens. 1999; 17: 555-560.
28. Phillips M, Speakman E, Kimura B. Levels of angiotensin and molecular biology of the tissue rennin angiotensin system. Regul Pept. 1993; 434: 1-20.
29. Velasquez M, Bhathena S, Striffler J, Thibault N, Scalbert E. Role of angiotensin-converting enzyme inhibition in glucose metabolism and renal injury in diabetes. Metabolism. 1998; 47 (12 suppl 1): 7-11.
30. Gunes HV, Ata N, Degirmenci I, Basaran A, Timuralp B, Dikmen M, et al. Frequency of angiotensin-converting enzyme gene polymorphism in Turkish hypertensive patients. Int J Clin Pract. 2004; 58: 838-843.
31. Sassano P, Chatellier G, Billaud E, Alhenc-Gelas F, Corvol P, Menard J. Treatment of mild to moderate hypertension with or without the converting enzyme inhibitor enalapril. A six-month double-blind trial. Am J Med. 1987; 83: 227-235.
32. Bhavani BA, Padmal T, Sastry BKS, Krishna-Reddy N, Nausheen K. The insertion/deletion polymorphism of ACE gene increase the susceptibility to hypertension and/or diabetes. Int J Hum Genet. 2005; 5: 247-252.
33. Turner T, Boerwinkle, Sing CF. Context-dependent associations of the ACE I/D polymorphism with blood pressure. Hypertension. 1999; 34: 773-778.
34. Muthumala A, Montgomery H, Palmen J, Cooper JA, Humphries SE. Angiotensin-converting enzyme genotype interacts with systolic blood pressure to determine coronary heart disease risk in healthy middle-aged men. Hypertension. 2007; 50: 348-352.
35. Araz M, Yilmaz N, Gungor K, Okan V, Kepekci Y, Sukru-Aynacioglu A. Angiotensin-converting enzyme gene polymorphism and microvascular complications in Turkish type 2 diabetic patients. Diabetes Res Clin Prac. 2001; 54: 95-104.
36. Bengtsson K, Orho-Melander M, Lindblad U, Melander O, Bog-Hansen E, Ranstam J, et al. Polymorphism in the ACE but not in the angiotensinogen gene is associated with hypertension and type 2 diabetes. J Hypertens. 1999; 17: 1569-1575.